Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by wizzdumbon Mar 30, 2022 3:21pm
121 Views
Post# 34560177

RE:RE:RE:AGM

RE:RE:RE:AGMExcellent meeting, lots of great info. Key takeaways for me were that they are serious about turning this into a  $100-200M business in the next couple of years and that they are on the right track as to making this a reality. Ramp up already happening and will be completed in the next few months. Don't expect press release on every new order or partnership, looks like they are going to just release big numbers with every quarterly result and wait for the market to take notice. I understand to an extent why they are doing this but hope there will still be announcements of the really big orders/partnerships as we need as much help as we can get in terms of awareness. Overall great update and will sleep well knowing the company is in great hands and we just need some patience for the share price to follow. 
<< Previous
Bullboard Posts
Next >>